We are glad to inform, that due to the development of ophthalmic intravitreal implants we are establishing new R&D Center in Bydgoszcz – just a few kilometers from our headquarter.

Our main goal is to provide scientific researches on modern ophthalmic drug formulations with Hot Melt Extrusion (HME) technology, to help treat glaucoma and Age-related macular degeneration (AMD).The Centre, co-financed by the Ministry of Investment and Development, is an extension of the existing field of activity, focusing primarily on the design of medical equipment and applicators of pharmacological substances.

The long-term goal of the Centre is to design, study, certify and, after appropriate clinical trials, introduce both a new type of intraocular injector to the global market and an intravitreal implant containing a combination of proper active pharmaceutical ingredients. An important part of the Centre is the Laboratory of HME Drug Formulations based on pharmaceutical polymers as API carriers.

This is a peculiar event for Passio, because developing innovative forms of medicines, used not only in ophthalmology but also in many other fields of medicine and pharmacy, was our goal a couple of years ago, and today we’ve finally achieve it.